Turkey

 

Booking data shows outpatient has all but stopped

Patient footfall for outpatient care across the world has all but stopped. Exclusive data from DocPlanner shows which specialities have seen the biggest drop in appointments booked and where telemedicine is really picking up some of the slack. We assess this against outpatient volumes in Singapore during SARS to see when it might pick up.

COVID-19: Care sector confronts crisis, hospitals hit hard

In the second of our two-part deep dive into how COVID-19 is hitting healthcare markets across EMEA, we ask how hospitals are coping with spiralling staff sickness and a flood of patients, and whether the care and dialysis sectors can stay afloat given the risk the virus poses to their most vulnerable patients.

FREE BLOG Europe’s €18bn fragmented private imaging sector ripe for change

What has emerged during our research for HBI Intelligence's imaging report, now live on our site, is how fragmented the sector is compared to other services. It will be utterly revolutionised by regulatory and tariff changes, AI/teleradiology and changing service-supplier dynamics; it's just no one is sure exactly how.

Turkey looks to cut imaging over-use

Independent sources tell HBI the Turkish government cut tariffs for imaging by, on average, 5% last year as part of a move to crack down on unnecessary scans.

Interview: Burcu Ozturk, CFO, MLP Care

We talk to the CFO of Turkey's largest private hospital group by beds, MLP Care, 18 months on from its Istanbul listing. Burcu Ozturk discusses the Turkish economy, MLP's postponed M&A plans and growing its private and international revenues amidst a stagnant statutory insurance segment.

IHH share price falls as Lira weakens

IHH Healthcare's share price fell 2.7% on the morning of Monday, July 8, as the Turkish lira weakened because of a high-level sacking by president Erdogan. The two might not be inextricably linked but it highlights the inherent risk to the Turkish business.

Interview: Julia Khalimova, Healthcare Quality and Patient Safety Specialist, International Finance Corporation (IFC)

A recent study in the Lancet showed that it was more dangerous to have access to poor quality health care than to have no access to health care. That is particularly true in Emerging Markets where quality varies dramatically. Julia Khalimova, Healthcare Quality and Patient Safety Specialist at IFC, the arm of the World Bank that invests in the private sectors of emerging markets, has been studying the field for ten years and IFC has recently launched a tool to enable operators to measure and improve. We talk to her about the problem. What progress has been made? And what is the best solution?

All change at IHH as CEO departure announced

Pan-Asian hospital group IHH Healthcare has announced its CEO will change at the end of 2019, a refinancing of up to $250m of non-Lira debt and its Fortis deal boosted Q1 2019 results, while its Turkish subsidiary Acibadem is reportedly eyeing an investment in London.

Find Us